Ftse Mib
36.160,72
-0,29%
DAX
20.917,14
0,09%
S&P 500
5.996,66
1,00%
NASDAQ
19.630,20
1,51%
Bitcoin
108.067,40
4,80%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ iSpecimen Inc (ISPC) iSpecimen Inc (ISPC) Notizie

iSpecimen Inc

ISPC
2,4896
-0,3604 (-12,65%)
18 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
16/1/202523:00EDGAR2Form 8-K - Current report
30/12/202422:15EDGAR2Form 8-K - Current report
20/12/202423:27EDGAR2Form 8-K - Current report
14/12/202400:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/12/202422:01EDGAR2Form 8-K - Current report
12/12/202423:26EDGAR2Form 8-K - Current report
12/11/202423:15EDGAR2Form 8-K - Current report
07/11/202413:30GLOBEiSpecimen Releases Cancer Biospecimen Offering; Orders..
07/11/202413:00GLOBEiSpecimen Reports Third Quarter 2024 Results
07/11/202412:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/10/202422:00EDGAR2Form 8-K - Current report
31/10/202420:07GLOBEiSpecimen Inc. Announces Closing of $5 Million Public..
31/10/202412:30EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
30/10/202413:30GLOBEiSpecimen Inc. Announces Pricing of $5 Million Public..
18/10/202423:25EDGAR2Form S-1 - General form for registration of securities under..
02/10/202422:15EDGAR2Form 8-K - Current report
30/9/202412:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/9/202401:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/9/202401:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202413:30GLOBEiSpecimen Secures $1 Million Loan; Appoints Three New Board..
25/9/202423:20EDGAR2Form 8-K - Current report
11/9/202422:45EDGAR2Form 8-K - Current report
11/9/202422:30GLOBEiSpecimen Announces 1-for-20 Reverse Stock Split
06/8/202415:00EDGAR2Form 8-K - Current report
06/8/202413:30GLOBEiSpecimen Reports Second Quarter 2024 Results
06/8/202412:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
25/7/202422:05GLOBEiSpecimen to Report Second Quarter 2024 Results on August 6,..
22/7/202423:10EDGAR2Form 8-K - Current report
08/7/202423:00EDGAR2Form 8-K - Current report
10/6/202415:00EDGAR2Form DEF 14A - Other definitive proxy statements
28/5/202422:52EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
20/5/202421:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/5/202421:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/5/202421:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/5/202421:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202422:16EDGAR2Form 8-K - Current report
07/5/202415:00EDGAR2Form 8-K - Current report
07/5/202413:30GLOBEiSpecimen Reports First Quarter 2024 Results
07/5/202412:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
25/4/202414:00GLOBEiSpecimen to Report First Quarter 2024 Financial Results on..
14/3/202413:00GLOBEiSpecimen Reports Full Year 2023 Results
13/3/202400:07GLOBEiSpecimen Reschedules Full Year 2023 Earnings Release and..
05/3/202422:30GLOBEiSpecimen to Report Full Year 2023 Financial Results on..
05/3/202415:26EDGAR2Form 8-K - Current report
05/3/202415:24EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
15/2/202423:09EDGAR2Form 8-K - Current report
23/1/202413:30GLOBEiSpecimen and TriMetis Life Sciences Announce Strategic..
22/1/202422:15GLOBEMaxim Group LLC to Host the 2024 Healthcare IT Virtual..
Apertura: 3,18 Min: 2,30 Max: 3,3795
Chiusura: 2,85

La tua Cronologia

NASDAQ
ISPC
iSpecimen
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network